GenSight BiologicsSIGHT 
$0.42-1.44%24h
-1.44%24h
Global rank28490
Market cap$27.15M
Change 7d-0.27%
YTD Performance-16.72%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of GenSight Biologics (SIGHT)
As of November 2024, GenSight Biologics has a market cap of $27.15M. This makes GenSight Biologics the world's 28490th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of GenSight Biologics from 2016 to 2024
-
Value:-
Market cap history of GenSight Biologics from 2016 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $28.60M | -13.91% |
| 2023 | $33.22M | -86.32% |
| 2022 | $242.79M | -39.53% |
| 2021 | $401.52M | -22.02% |
| 2020 | $514.90M | 186.92% |
| 2019 | $179.46M | -25.38% |
| 2018 | $240.48M | -46.12% |
| 2017 | $446.29M | -20.26% |
| 2016 | $559.67M | - |
SIGHT Market Cap Today is $27.15M -1.44% - 19 Nov 2024
View largest stocks by market cap 
